Immune reconstitution after haploidentical hematopoietic stem cell transplantation

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Haploidentical hematopoietic stem cell transplantation (HSCT) is a widely adopted treatment for hematologic malignancies when matched donors are unavailable.
• This method provides rapid and nearly universal donor access for patients needing urgent transplantation.
• Significant challenges include high mortality rates due to serious infections and leukemia relapse, primarily linked to delayed immune reconstitution.

Purpose of the Study:

• To review recent advancements in immune recovery following haploidentical HSCT.
• To identify key immune subsets influencing clinical outcomes after transplantation.
• To discuss strategies aimed at accelerating immune reconstitution and improving patient survival.

Main Methods:

• Review of current literature on immune reconstitution after haploidentical HSCT.
• Analysis of immune subsets and their correlation with clinical outcomes.
• Evaluation of different strategies employed to enhance immune recovery post-transplant.

Main Results:

• Slow immune reconstitution remains a primary cause of mortality, especially after T cell-depleted grafts.
• Specific immune subsets have been identified as critical for successful immune recovery.
• Various strategies show promise in accelerating immune reconstitution post-haploidentical HSCT.

Conclusions:

• Optimizing immune recovery is essential for improving survival rates in haploidentical HSCT.
• A predictive, immune subset-guided approach may represent a future clinical strategy.
• Further research into immune reconstitution is vital for advancing HSCT efficacy.